Richard D. Carvajal
0000-0002-3796-1118
Publication & Citation Trends
Publications
0 total
Global practice patterns and outcomes for metastatic uveal melanoma treated regionally versus systemically.
Cited by 0
Semantic Scholar
Concurrent local therapy extends clinical benefit of tebentafusp in metastatic uveal melanoma patients
Cited by 3
Semantic Scholar
Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 Patients
Cited by 0
Semantic Scholar
A randomized, phase 2/3 clinical trial investigating RP2 plus nivolumab vs ipilimumab plus nivolumab in immune checkpoint inhibitor-naïve patients with metastatic uveal melanoma.
Cited by 1
Semantic Scholar
Intramedullary primary spinal cord melanoma: illustrative case
Cited by 1
Semantic Scholar
Abstract A006: Biomarker analyses of WEE1 inhibition in patients with refractory CCNE1 amplified solid tumors
Cited by 1
Semantic Scholar
Evolution of the tumor immune landscape during treatment with tebentafusp, a T cell receptor-CD3 bispecific OA
Cited by 7
Semantic Scholar
Research Topics
Ocular Oncology and Treatments
(181)
Cancer Immunotherapy and Biomarkers
(174)
Immunotherapy and Immune Responses
(148)
CAR-T cell therapy research
(100)
Cancer Genomics and Diagnostics
(87)
Affiliations
The University of Sydney
Northwell Health
Georgia Institute of Technology
Mater Health Services
Hudson Institute